NovaBay Pharmaceuticals, Inc. (NBY): Price and Financial Metrics

NovaBay Pharmaceuticals, Inc. (NBY)

Today's Latest Price: $0.61 USD

0.01 (-1.95%)

Updated Oct 30 8:00pm

Add NBY to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 384 in Biotech

See all "A" rated Strong Buy stocks

NBY Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for NBY is 9.35 -- better than 96.57% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 10.72 for NovaBay Pharmaceuticals Inc; that's greater than it is for 94.09% of US stocks.
  • With a year-over-year growth in debt of -69.39%, NovaBay Pharmaceuticals Inc's debt growth rate surpasses merely 3.38% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to NovaBay Pharmaceuticals Inc, a group of peers worth examining would be HBB, WTER, APAM, KIRK, and SYPR.
  • NBY's SEC filings can be seen here. And to visit NovaBay Pharmaceuticals Inc's official web site, go to

NBY Stock Price Chart Interactive Chart >

Price chart for NBY

NBY Price/Volume Stats

Current price $0.61 52-week high $1.94
Prev. close $0.62 52-week low $0.24
Day low $0.60 Volume 396,427
Day high $0.63 Avg. volume 3,548,252
50-day MA $0.77 Dividend yield N/A
200-day MA $0.85 Market Cap 25.36M

NovaBay Pharmaceuticals, Inc. (NBY) Company Bio

NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes non-antibiotic anti-infective products for the eye care market in the United States. The company was founded in 2000 and is based in Emeryville, California.

NBY Latest News Stream

Event/Time News Detail
Loading, please wait...

NBY Latest Social Stream

Loading social stream, please wait...

View Full NBY Social Stream

Latest NBY News From Around the Web

Below are the latest news stories about NovaBay Pharmaceuticals Inc that investors may wish to consider to help them evaluate NBY as an investment opportunity.

NovaBay rallies on availability at

NovaBay Pharmaceuticals (NBY) surges 36% premarket on the launch of Avenova on“Avenova has always demonstrated the ability to kill a wide variety of pathogens, and we now have laboratory results proving it as a COVID-killer on hard surfaces,” said Justin Hall, CEO.Avenova is used for eyelid and eyelash cleansing and removal of foreign...

Seeking Alpha | August 18, 2020

NovaBay Pharmaceuticals, Inc. (NBY) CEO Justin Hall on Q2 2020 Results - Earnings Call Transcript

NovaBay Pharmaceuticals, Inc. (NBY) Q2 2020 Earnings Conference Call August 6, 2020 16:30 ET Company Participants Yvonne Briggs - Vice President, LHA Justin Hall - President & Chief Executive Officer Andrew Jones - Chief Financial Officer & Treasurer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Presentation Operator Welcome to...

SA Transcripts on Seeking Alpha | August 9, 2020

NovaBay Pharmaceuticals Reports Second Quarter 2020 Financial Results

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay reports second quarter 2020 financial results.

Business Wire | August 6, 2020

NovaBay Pharmaceuticals to Hold Second Quarter 2020 Conference Call on August 6

NovaBay Pharmaceuticals to Hold Second Quarter 2020 Conference Call on August 6

Business Wire | July 27, 2020

NovaBay Pharmaceuticals Announces Laboratory Results Confirm Avenova Kills SARS-CoV-2 (COVID-19 Virus)

NovaBay Pharmaceuticals Announces Laboratory Results Confirm Avenova Kills SARS-CoV-2

Business Wire | July 13, 2020

Read More 'NBY' Stories Here

NBY Price Returns

1-mo -15.79%
3-mo -50.41%
6-mo -40.78%
1-year 5.63%
3-year -86.88%
5-year -87.16%
YTD -4.69%
2019 -16.88%
2018 -80.00%
2017 16.67%
2016 63.37%
2015 -87.17%

Continue Researching NBY

Want to see what other sources are saying about NovaBay Pharmaceuticals Inc's financials and stock price? Try the links below:

NovaBay Pharmaceuticals Inc (NBY) Stock Price | Nasdaq
NovaBay Pharmaceuticals Inc (NBY) Stock Quote, History and News - Yahoo Finance
NovaBay Pharmaceuticals Inc (NBY) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8292 seconds.